Clinical Pharmacology

Completed

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects

NCT03517930

Conditions

Clinical Pharmacology

Locations

• Frontage Clinical Services — Secaucus, New Jersey, United States

View Trial Details

Completed

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects

NCT03517943

Conditions

Clinical Pharmacology

Locations

• Frontage Clinical Services — Secaucus, New Jersey, United States

View Trial Details

Completed

Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects

NCT02629562

Conditions

Clinical Pharmacology

Locations

• Nuvisan GmbH — Neu-Ulm, Germany

View Trial Details

Completed

Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.

NCT03136666

Conditions

Clinical Pharmacology

Locations

• Wuppertal, North Rhine-Westphalia, Germany

View Trial Details

Completed

Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

NCT03074058

Conditions

Clinical Pharmacology

Locations

• Fukuoka, Japan

View Trial Details

Completed

TAK-114 Single- and Multiple-Dose Phase 1 Study

NCT02286518

Conditions

Clinical Pharmacology

Locations

• Sumida-ku, Tokyo, Japan

View Trial Details

Completed

A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects

NCT02113020

Conditions

Clinical Pharmacology

Locations

• Kumamoto, Japan

View Trial Details